An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to message these profiles privately for supplier links, while also receiving discount codes.
Active Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where groups with numerous of members share comparison photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Express Worries
Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.
Several experts said the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, legal action or prison.
Service Reaction and Content Removal
According to TikTok, the platform has taken down violative material and banned associated hashtags and query recommendations. The company said it was committed to maintaining the platform secure and allocating resources in enhancing enforcement strategies.
Online Trading Operations
Investigations also found communities with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, positive reviews and detailed guides for preparing or administering at residence.
After moments of entering one community, a vendor shared WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.
Product Details and Costs
Inside these groups, posts show dark colored packages with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram stated it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is valid, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her team has previously seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may expose patients to possibly significant medical dangers”.
